ERAS

Erasca, Inc.

16.03

+0.33+2.10%

Pre Market: 16.01 -0.02 -0.12%08:30 09/11 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE15.37/15.70

TODAY RANGE15.37-17.25

VOL4.08K

MARKET CAP5.61B

52 WEEK RANGE1.525-24.28

AVG VOL (3M)4.58M

% TURNOVER2.36%

TURNOVER0

P/E (TTM)-16.7889

% RANGE11.97%

EPS(TTM)-0.9548

P/E(FORWARD)-16.1929

P/B13.85

BVPS1.158

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.67B

SHARES OUTSTANDING349.76M

NEXT EARNINGS11/10-11/16

FREE FLOAT291.15M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·09/02 12:18
J.P. Morgan Keeps Their Buy Rating on Erasca (ERAS)
TipRanks·08/27 13:10
Erasca price target raised to $33 from $25 at JPMorgan
Seeking Alpha·08/25 13:20
Alger Mid Cap 40 ETF Q2 2026 Portfolio Review
TipRanks·08/25 12:30
Analysts Have Conflicting Sentiments on These Healthcare Companies: Capricor Therapeutics (CAPR), Ansell (OtherANSLF) and Erasca (ERAS)
TipRanks·08/25 11:30
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Erasca (ERAS) and GlaxoSmithKline (GSK)
TipRanks·08/24 13:00
Morning Movers: Regenxbio sinks following clinical hold on RGX-121
NASDAQ·08/24 13:00
Erasca's Pancreatic Cancer Drug Gains FDA Fast Track Designation
TipRanks·08/24 12:48
Erasca Wins FDA Fast Track for Pancreatic Therapy
TipRanks·08/24 12:10
Erasca granted Fast Track Designation for ERAS-0015
TipRanks·08/17 12:23
Stifel Nicolaus Reaffirms Their Buy Rating on Erasca (ERAS)
TipRanks·08/17 10:17
Erasca price target raised to $22 from $18 at H.C. Wainwright
TipRanks·08/16 13:45
Erasca price target raised to $20 from $18 at BofA
Dow Jones·08/14 18:33
Erasca Is Maintained at Neutral by B of A Securities
Dow Jones·08/14 18:33
Erasca Price Target Raised to $20.00/Share From $18.00 by B of A Securities
TipRanks·08/14 11:15
Erasca (ERAS) Gets a Hold from Bank of America Securities

Same Industry

Name/Symbol

Change%

Price

ERAS

REGN

GridAI Tech

GRDX

-1.32%

2.980

BNTX

United Therapeutics Corp.

UTHR

-0.54%

487.61

SIGA

VRTX

Moderna

MRNA

-2.23%

145.55

CRL

MEDP

Talphera Inc

TLPH

0.00%

1.200

CBPO

ICON plc

ICLR

+0.78%

164.85

Iqvia Hldgs Inc

IQV

-1.42%

267.77

MOLN

ARCT

Gilead Sciences Inc

GILD

-0.58%

144.81

PRAH

APVO

INCY

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.